Lifeward (NASDAQ:LFWD) Stock Price Down 4.6% – Here’s Why

Lifeward Ltd. (NASDAQ:LFWD) fell 4.6% during trading on Monday . The company traded as low as $7.55 and last traded at $7.55. Approximately 15,948 shares changed hands during mid-day trading, a decline of 10% from the average session volume of 17,779 shares. The stock had previously closed at $7.91.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on LFWD. Zacks Research lowered shares of Lifeward from a “hold” rating to a “strong sell” rating in a research report on Wednesday, June 3rd. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Lifeward in a report on Friday. One equities research analyst has rated the stock with a Buy rating and two have assigned a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Reduce” and an average target price of $10.00.

Lifeward Stock Performance

The firm’s fifty day moving average price is $7.34 and its 200-day moving average price is $7.06. The company has a market cap of $20.32 million, a P/E ratio of -0.37 and a beta of 0.37. The company has a current ratio of 2.40, a quick ratio of 1.82 and a debt-to-equity ratio of 1.16.

Lifeward (NASDAQ:LFWD) last released its earnings results on Friday, May 15th. The company reported ($6.70) earnings per share for the quarter, missing the consensus estimate of ($1.18) by ($5.52). The company had revenue of $3.92 million during the quarter, compared to the consensus estimate of $5.78 million. Lifeward had a negative net margin of 123.66% and a negative return on equity of 243.14%. As a group, research analysts forecast that Lifeward Ltd. will post -4.27 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. HRT Financial LP boosted its stake in Lifeward by 149.7% during the fourth quarter. HRT Financial LP now owns 49,081 shares of the company’s stock worth $28,000 after buying an additional 29,423 shares in the last quarter. Virtu Financial LLC raised its stake in shares of Lifeward by 158.0% in the 4th quarter. Virtu Financial LLC now owns 60,474 shares of the company’s stock valued at $35,000 after buying an additional 37,037 shares in the last quarter. Jane Street Group LLC lifted its holdings in shares of Lifeward by 77.3% during the 4th quarter. Jane Street Group LLC now owns 68,631 shares of the company’s stock worth $40,000 after acquiring an additional 29,927 shares during the period. Finally, Citadel Advisors LLC lifted its holdings in shares of Lifeward by 1,271.8% during the 3rd quarter. Citadel Advisors LLC now owns 214,006 shares of the company’s stock worth $152,000 after acquiring an additional 198,406 shares during the period. 26.76% of the stock is currently owned by institutional investors and hedge funds.

Lifeward Company Profile

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.